MGX
Metagenomi Therapeutics, Inc.After hours0.8612−0.06 −6.12%USD
NasdaqGS · as of Oct 14, 16:00 ET · 15m delayAfter hours 0.8600 −0.14%
Open
0.8946
Prev close
0.9173
Day range
0.86000.9500
52-week range
0.86003.95
Volume
293.50K1.93×
Mkt cap
32.53M
P/E ttm
—
Fwd P/E
-0.47
EPS ttm
-2.49
Div yield
0.00%
Earnings
—
From 52w high
−78.20%
MGX earnings and estimates
MGX Next Report
Yahoo Finance · Nasdaq
No upcoming report date is published for MGX.
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Aug 10, 2026 AMC | −0.73 | −0.52 | −40.38% | $0 | −1.6% | −0.8% |
| Mar '26 | May 11, 2026 AMC | −0.61 | −0.55 | −10.91% | $1.25M | 0.0% | −5.9% |
| Dec '25 | Mar 5, 2026 AMC | −0.60 | −0.58 | −2.56% | $3.91M | −8.1% | −2.5% |
| Sep '25 | Nov 11, 2025 AMC | −0.55 | −0.53 | −3.13% | $8.66M | −15.5% | −22.7% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −0.62 | −0.75−0.55 | −12.3% | $2.06M | −76.2% | −0.50 −22.7% | −0.52 −19.9% | 0 / 3 |
| Next quarter Dec 2026 | −0.52 | −0.61−0.33 | +12.9% | $2.06M | −47.3% | −0.52 −0.5% | −0.46 −13.6% | 0 / 3 |
| Current year Dec 2026 | −2.42 | −2.53−2.16 | −2.4% | $5.12M | −79.7% | −2.16 −11.9% | −2.11 −14.6% | 0 / 3 |
| Next year Dec 2027 | −1.83 | −2.30−1.56 | +24.1% | $7.48M | +46.1% | −2.12 +13.4% | −1.47 −24.8% | 1 / 2 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −0.74 | −0.75−0.73 | 2 | 0 / 0 |
| Dec 2026 | −0.53 | −0.73−0.33 | 2 | 0 / 0 |
| Mar 2027 | −0.36 | — | 1 | 0 / 0 |
| Jun 2027 | −0.38 | — | 1 | 0 / 0 |
| Sep 2027 | −0.40 | — | 1 | 0 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Dec 2026 | −2.50 | −2.80−2.16 | 3 | 0 / 0 |
| Dec 2027 | −1.76 | −2.05−1.56 | 3 | 0 / 0 |
| Dec 2028 | −0.79 | — | 1 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.